WeInfuse Revenue and Competitors
Estimated Revenue & Valuation
- WeInfuse's estimated annual revenue is currently $5.5M per year.
- WeInfuse's estimated revenue per employee is $102,868
Employee Data
- WeInfuse has 53 Employees.
- WeInfuse grew their employee count by 15% last year.
WeInfuse's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | VP Sales | Reveal Email/Phone |
4 | Co-Founder and Chief Operating Officer | Reveal Email/Phone |
5 | Director Product & Integrations | Reveal Email/Phone |
6 | Director Partnerships | Reveal Email/Phone |
7 | Director People Operations | Reveal Email/Phone |
8 | Director Data and Insights | Reveal Email/Phone |
9 | Co Founder, Product Manager & CEO | Reveal Email/Phone |
10 | Full Stack Engineer | Reveal Email/Phone |
WeInfuse Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.5M | 121 | 12% | N/A | N/A |
#2 | $90.4M | 499 | 24% | N/A | N/A |
#3 | $2M | 20 | -23% | N/A | N/A |
#4 | $276.4M | 1424 | 33% | $261M | N/A |
#5 | $406.7M | 2600 | 8% | $26.1M | N/A |
#6 | $14.8M | 102 | -61% | N/A | N/A |
#7 | $8.6M | 66 | -1% | N/A | N/A |
#8 | $13.2M | 91 | -5% | $752.5M | N/A |
#9 | $36.5M | 229 | 6% | N/A | N/A |
#10 | $56.6M | 312 | 23% | N/A | N/A |
What Is WeInfuse?
WeInfuse is a webâ€based application that centralizes and streamlines all aspects of infusion center management solving extensive and expensive pain points for the significantly under-resourced channel that delivers specialty biologic infusion medications, the fastest growing segment in pharma.
keywords:N/AN/A
Total Funding
53
Number of Employees
$5.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.5M | 53 | N/A | N/A |
#2 | $13.7M | 53 | -17% | N/A |
#3 | $8M | 53 | -7% | N/A |
#4 | $12.9M | 53 | 20% | N/A |
#5 | $12.9M | 53 | 6% | N/A |